Journal: Molecular Pathology in Clinical Practice

Article Title: Bacterial Infections

doi: 10.1007/978-3-319-19674-9_49

Figure Lengend Snippet: FDA-cleared molecular tests for the detection of methicillin-resistant Staphylococcus aureus (MRSA) directly from patient specimens

Article Snippet: Filmarray BCID , BioFire , MRSA/SA , Positive blood culture bottles , [ ] .

Techniques: Diagnostic Assay

Journal: Molecular Pathology in Clinical Practice

Article Title: Bacterial Infections

doi: 10.1007/978-3-319-19674-9_49

Figure Lengend Snippet: FDA-cleared molecular tests for identification of potential pathogens from positive blood culture bottles

Article Snippet: Filmarray BCID , BioFire , MRSA/SA , Positive blood culture bottles , [ ] .

Techniques: Real-time Polymerase Chain Reaction, Multiplex Assay

Journal: PLoS ONE

Article Title: Clinical utility of the BioFire FilmArray Blood Culture Identification panel in the adjustment of empiric antimicrobial therapy in the critically ill septic patient

doi: 10.1371/journal.pone.0254389

Figure Lengend Snippet: Impact of the BioFire FilmArray BCID panel on the adjustment of antimicrobial therapy.

Article Snippet: With regards to Gram positive bacteria, the BioFire FilmArray BCID results were available 24.7 hours before preliminary organism identification and 47.4 hours before final identification and susceptibility [ ].

Techniques:

Journal: BioMed Research International

Article Title: Comparison of the Fully Automated FilmArray BCID Assay to a 4-Hour Culture Test Coupled to Mass Spectrometry for Day 0 Identification of Microorganisms in Positive Blood Cultures

doi: 10.1155/2018/7013470

Figure Lengend Snippet: Number of pathogens detected in the 153 blood specimen bottles by the three techniques that were compared in this study. The MALDI-TOF MS technique was taken as the gold standard.

Article Snippet: The FilmArray BCID assay (BioFire Diagnostics, Salt Lake City, UT, USA, and bioMérieux, Marcy l'Etoile, France) was performed following manufacturer's recommendations.

Techniques: Bacteria

Journal: BioMed Research International

Article Title: Comparison of the Fully Automated FilmArray BCID Assay to a 4-Hour Culture Test Coupled to Mass Spectrometry for Day 0 Identification of Microorganisms in Positive Blood Cultures

doi: 10.1155/2018/7013470

Figure Lengend Snippet: Pathogens identified in the 8 blood culture bottles exhibiting coinfection.

Article Snippet: The FilmArray BCID assay (BioFire Diagnostics, Salt Lake City, UT, USA, and bioMérieux, Marcy l'Etoile, France) was performed following manufacturer's recommendations.

Techniques:

Journal: BioMed Research International

Article Title: Comparison of the Fully Automated FilmArray BCID Assay to a 4-Hour Culture Test Coupled to Mass Spectrometry for Day 0 Identification of Microorganisms in Positive Blood Cultures

doi: 10.1155/2018/7013470

Figure Lengend Snippet: Comparative results of the two rapid techniques on the 153 blood culture bottles of the study. Success was defined by the capacity to obtain the same result (absence or presence of one or two microorganisms) as that of the reference method (MALDI-TOF MS).

Article Snippet: The FilmArray BCID assay (BioFire Diagnostics, Salt Lake City, UT, USA, and bioMérieux, Marcy l'Etoile, France) was performed following manufacturer's recommendations.

Techniques:

Journal: Open Forum Infectious Diseases

Article Title: Impact of a Multiplex PCR Assay for Bloodstream Infections With and Without Antimicrobial Stewardship Intervention at a Cancer Hospital

doi: 10.1093/ofid/ofy258

Figure Lengend Snippet: Flow diagram for participants included in the study. Unadjusted mean time to appropriate antimicrobial therapy using a 1-way analysis of variance test as a comparison: no statistical difference in uncontrolled means between PRE, POST, and POST-AS groups (44 hours, 25 hours, 26 hours; P = .069) at an alpha = .05 level. Abbreviations: BCID, multiplex polymerase chain reaction–based blood culture identification; BSI, bloodstream infection; PRE, before BCID implementation; OSH, outside hospital; POST, after BCID implementation; POST-AS, BCID coupled with antimicrobial stewardship.

Article Snippet: Biofire FilmArray Multiplex PCR BCID was implemented in November 2014 without AS intervention, followed by AS notification of results and active guidance on therapy communicated to providers in October 2016.

Techniques: Multiplex Assay, Polymerase Chain Reaction, Infection